We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Ming Lim

Ming Y. Lim MD

Assistant Professor, Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, Utah

Dr. Ming Y. Lim is an Assistant Professor in the Division of Hematology and Hematologic Malignancies at the University of Utah. She completed residency in internal medicine at the Mayo Clinic Rochester and fellowship training in hematology and oncology at University of North Carolina at Chapel Hill. Her clinical interest lies in the field of hemostasis and thrombosis. Her research interest is focused on complications affecting patients with congenital bleeding disorders, specifically hemophilia patients with inhibitors. She is the Medical Director for the Utah Center for Bleeding & Clotting Disorders at University of Utah Health. Nationally, she serves on the American Board of Internal Medicine Hematology Approval Committee and is the Chair of the American Society of Hematology Subcommittee on Stewardship and Systems-Based Hematology. She also serves on the National Comprehensive Cancer Network (NCCN) Cancer-Associated Venous Thromboembolic Disease Panel.

Disclosures

Dr. Ming Y. Lim has received honorarium for participation in advisory board from Sanofi Genzyme, Argenx, Dova Pharmaceuticals and Hema Biologics. Dr. Lim also received honorarium and travel expenses for educational participation in the Hemostasis and Thrombosis Research Society Trainee Workshop which was supported by Novo Nordisk.